Glioma infiltration and extracellular matrix: key players and modulators

GLIA

Volumn 66, Issue 8, 2018, Pages 1542-1565

  Ferrer, Valéria Pereira ^a   Moura Neto, Vivaldo ^a   Mentlein, Rolf ^b  

^a Paulo Niemeyer Brain Institute   (Brazil)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

extracellular matrix; glioma; glycosidases; infiltration; proteases

Indexed keywords

BINDING PROTEIN; CHEMOKINE; GLYCOPROTEIN; GLYCOSAMINOGLYCAN; GLYCOSIDASE; GROWTH FACTOR; HERMES ANTIGEN; HYALURONIC ACID; HYALURONIC ACID BINDING PROTEIN; INTEGRIN; MICRORNA; PROTEINASE; PROTEOGLYCAN; TENASCIN; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; BRAIN TISSUE; CELL INFILTRATION; CELL MIGRATION; CLINICAL ASSESSMENT; CYTOSKELETON; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; GLIOMA; GLIOMA CELL; HUMAN; NONHUMAN; OUTCOME ASSESSMENT; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR INVASION;

EID: 85042195480     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.23309     Document Type: Review

References (395)

1. Aggarwal, N., & Sloane, B. F. (2014). Cathepsin B: Multiple roles in cancer. Proteomics. Clinical Applications, 8, 427–437
2. Agochiya, M., Brunton, V. G., Owens, D. W., Parkinson, E. K., Paraskeva, C., Keith, W. N., & Frame, M. C. (1999). Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells. Oncogene, 18, 5646–5653
3. Ahluwalia, M. S., Patton, C., Stevens, G., Tekautz, T., Angelov, L., Vogelbaum, M. A., … Suh, J. H. (2011). Phase II trial of ritonavir/lopinavir in patients with progressive or recurrent high-grade gliomas. Journal of Neurooncology, 102, 317–321
4. Akiyama, Y., Jung, S., Salhia, B., Lee, S., Hubbard, S., Taylor, M., … Rutka, J. T. (2001). Hyaluronate receptors mediating glioma cell migration and proliferation. Journal of Neurooncology, 53, 115–127
5. Alapati, K., Kesanakurti, D., Rao, J. S., & Dasari, V. R. (2014). uPAR and cathepsin B-mediated compartmentalization of JNK regulates the migration of glioma-initiating cells. Stem Cell Research, 12, 716–729
6. Ali, S., & Lazennec, G. (2007). Chemokines: Novel targets for breast cancer metastasis. Cancer Metastasis Review, 26, 401–420
7. Alonso-Basanta, M., Fang, P., Maity, A., Hahn, S. M., Lustig, R. A., & Dorsey, J. F. (2014). A phase I study of nelfinavir concurrent with temozolomide and radiotherapy in patients with glioblastoma multiforme. Journal of Neurooncology, 116, 365–372
8. Alves, T. R., da Fonseca, A. C., Nunes, S. S., da Silva, A. O., Dubois, L. G., Faria, J., … Legrand, C. (2011a). Tenascin-C in the extracellular matrix promotes the selection of highly proliferative and tubulogenesis-defective endothelial cells. Experimental Cell Research, 317, 2073–2085
9. Alves, T. R., Lima, F. R., Kahn, S. A., Lobo, D., Dubois, L. G., Soletti, R., … Neto, V. M. (2011b). Glioblastoma cells: A heterogeneous and fatal tumor interacting with the parenchyma. Life Science, 89, 532–539
10. Andrews, W. D., Barber, M., & Parnavelas, J. G. (2007). Slit-Robo interactions during cortical development. Journal of Anatomy, 211, 188–198
11. Anglicheau, D., Muthukumar, T., & Suthanthiran, M. (2010). MicroRNAs: Small RNAs with big effects. Transplantation, 90, 105–112
12. Antalis, T. M., Conway, G. D., Peroutka, R. J., & Buzza, M. S. (2016). Membrane-anchored proteases in endothelial cell biology. Current Opinion in Hematology, 23, 243–252
13. Arden, J. D., Lavik, K. I., Rubinic, K. A., Chiaia, N., Khuder, S. A., Howard, M. J., … Eisenmann, K. M. (2015). Small-molecule agonists of mammalian Diaphanous-related (mDia) formins reveal an effective glioblastoma anti-invasion strategy. Molecular Biology of the Cell, 26, 3704–3718
14. Assmann, V., Marshall, J. F., Fieber, C., Hofmann, M., & Hart, I. R. (1998). The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells. Journal of Cell Science, 111(Pt 12), 1685–1694
15. Awad, A. J., Burns, T. C., Zhang, Y., & Abounader, R. (2014). Targeting MET for glioma therapy. Neurosurgical Focus, 37, E10
16. Bajetto, A., Barbieri, F., Dorcaratto, A., Barbero, S., Daga, A., Porcile, C. … Others, (2006). Expression of CXC chemokine receptors 1–5 and their ligands in human glioma tissues: Role of CXCR4 and SDF1 in glioma cell proliferation and migration. Neurochemistry International, 49, 423–432
17. Balça-Silva, J., Matias, D., do Carmo, A., Girão, H., Moura-Neto, V., Sarmento-Ribeiro, A. B., & Lopes, M. C. (2015). Tamoxifen in combination with temozolomide induce a synergistic inhibition of PKC-pan in GBM cell lines. Biochimica Biophysica Acta, 1850, 722–732
18. Ballard, M. S., & Hinck, L. (2012). A roundabout way to cancer. Advances in Cancer Research, 114, 187–235
19. Barash, U., Cohen-Kaplan, V., Arvatz, G., Gingis-Velitski, S., Levy-Adam, F., Nativ, O., … Vlodavsky, I. (2010). A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics. Faseb Journal, 24, 1239–1248
20. Baumann, F., Leukel, P., Doerfelt, A., Beier, C. P., Dettmer, K., Oefner, P. J., … Bogdahn, U. (2009). Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2. Neuro Oncology, 11, 368–380
21. Beadle, C., Assanah, M. C., Monzo, P., Vallee, R., Rosenfeld, S. S., & Canoll, P. (2008). The role of myosin II in glioma invasion of the brain. Molecular Biology of the Cell, 19, 3357–3368
22. Bello, L., Francolini, M., Marthyn, P., Zhang, J., Carroll, R. S., Nikas, D. C., … Black, P. M. (2001). Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery. Neurosurgery, 49, 380–389; discussion 390
23. Binder, D. K., & Berger, M. S. (2002). Proteases and the biology of glioma invasion. Journal of Neurooncology, 56, 149–158
24. Bodmer, S., Strommer, K., Frei, K., Siepl, C., de Tribolet, N., Heid, I., & Fontana, A. (1989). Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2. Journal of Immunology, 143, 3222–3229
25. Bogdahn, U., Hau, P., Stockhammer, G., Venkataramana, N. K., Mahapatra, A. K., Suri, A., … Schlingensiepen, K. H. Trabedersen Glioma Study Group. (2011). Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: Results of a randomized and controlled phase IIb study. Neuro Oncology, 13, 132–142
26. Boregowda, R. K., Appaiah, H. N., Siddaiah, M., Kumarswamy, S. B., Sunila, S., Thimmaiah, K. N., … Banerjee, S. (2006). Expression of hyaluronan in human tumor progression. Journal of Carcinogenesis, 5, 2
27. Boyd, A. W., Bartlett, P. F., & Lackmann, M. (2014). Therapeutic targeting of EPH receptors and their ligands. Nature Reviews Drug Discovery, 13, 39–62
28. Brat, D. J., Castellano-Sanchez, A. A., Hunter, S. B., Pecot, M., Cohen, C., Hammond, E. H., … Van Meir, E. G. (2004). Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Research, 64, 920–927
29. Brooks, P. C., Stromblad, S., Sanders, L. C., von Schalscha, T. L., Aimes, R. T., Stetler-Stevenson, W. G., … Cheresh, D. A. (1996). Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell, 85, 683–693
30. Brosicke, N., & Faissner, A. (2015). Role of tenascins in the ECM of gliomas. Cell Adhesion & Migration, 9, 131–140
31. Broussard, J. A., Webb, D. J., & Kaverina, I. (2008). Asymmetric focal adhesion disassembly in motile cells. Current Opinion in Cell Biology, 20, 85–90
32. Calatozzolo, C., Maderna, E., Pollo, B., Gelati, M., Marras, C., Silvani, A., … Salmaggi, A. (2006). Prognostic value of CXCL12 expression in 40 low-grade oligodendrogliomas and oligoastrocytomas. Cancer Biology & Therapy, 5, 827–832
33. Calderwood, D. A., Shattil, S. J., & Ginsberg, M. H. (2000). Integrins and actin filaments: Reciprocal regulation of cell adhesion and signaling. Journal of Biological Chemistry, 275, 22607–22610
34. Canoll, P., & Goldman, J. E. (2008). The interface between glial progenitors and gliomas. Acta Neuropathology, 116, 465–477
35. Carrasco-García, E., Saceda, M., & Martínez-Lacaci, I. (2014). Role of receptor tyrosine kinases and their ligands in glioblastoma. Cells, 3, 199–235
36. Cassinelli, G., Zaffaroni, N., & Lanzi, C. (2016). The heparanase/heparan sulfate proteoglycan axis: A potential new therapeutic target in sarcomas. Cancer Letters, 382, 245–254
37. Chang, L., Zhao, D., Liu, H. B., Wang, Q. S., Zhang, P., Li, C. L. … Others, (2015). Activation of sonic hedgehog signaling enhances cell migration and invasion by induction of matrix metalloproteinase-2 and −9 via the phosphoinositide-3 kinase/AKT signaling pathway in glioblastoma. Molecular Medicine Reports, 12, 6702–6710
38. Charles, N. A., Holland, E. C., Gilbertson, R., Glass, R., & Kettenmann, H. (2012). The brain tumor microenvironment. Glia, 60, 502–514
39. Chedotal, A., Kerjan, G., & Moreau-Fauvarque, C. (2005). The brain within the tumor: New roles for axon guidance molecules in cancers. Cell Death Differentiation, 12, 1044–1056
40. Cheerathodi, M., Avci, N. G., Guerrero, P. A., Tang, L. K., Popp, J., Morales, J. E., … McCarty, J. H. (2016). The cytoskeletal adapter protein spinophilin regulates invadopodia dynamics and tumor cell invasion in glioblastoma. Molecular Cancer Research, 14, 1277–1287
41. Chen, X., Chen, L., Chen, J., Hu, W., Gao, H., Xie, B., … Wang, X. (2013). ADAM17 promotes U87 glioblastoma stem cell migration and invasion. Brain Research, 1538, 151–158
42. Cheng, S. Y., Sun, G., Schlaepfer, D. D., & Pallen, C. J. (2014). Grb2 promotes integrin-induced focal adhesion kinase (FAK) autophosphorylation and directs the phosphorylation of protein tyrosine phosphatase alpha by the Src-FAK kinase complex. Molecular Cell Biology, 34, 348–361
43. Chernov, A. V., Sounni, N. E., Remacle, A. G., & Strongin, A. Y. (2009). Epigenetic control of the invasion-promoting MT1-MMP/MMP-2/TIMP-2 axis in cancer cells. Journal of Biological Chemistry, 284, 12727–12734
44. Chetty, C., Vanamala, S. K., Gondi, C. S., Dinh, D. H., Gujrati, M., & Rao, J. S. (2012). MMP-9 induces CD44 cleavage and CD44 mediated cell migration in glioblastoma xenograft cells. Cell Signal, 24, 549–559
45. Chiquet-Ehrismann, R. (1995). Tenascins, a growing family of extracellular matrix proteins. Experientia, 51, 853–862
46. Chiquet-Ehrismann, R., Orend, G., Chiquet, M., Tucker, R. P., & Midwood, K. S. (2014). Tenascins in stem cell niches. Matrix Biology, 37, 112–123
47. Chiquet, M., Gelman, L., Lutz, R., & Maier, S. (2009). From mechanotransduction to extracellular matrix gene expression in fibroblasts. Biochimica Biophysica Acta, 1793, 911–920
48. Choi, K. Y., Swierczewska, M., Lee, S., & Chen, X. (2012). Protease-activated drug development. Theranostics, 2, 156–178
49. Chuang, Y. Y., Tran, N. L., Rusk, N., Nakada, M., Berens, M. E., & Symons, M. (2004). Role of synaptojanin 2 in glioma cell migration and invasion. Cancer Research, 64, 8271–8275
50. Claes, A., Idema, A. J., & Wesseling, P. (2007). Diffuse glioma growth: A guerilla war. Acta Neuropathology, 114, 443–458
51. Colin, C., Voutsinos-Porche, B., Nanni, I., Fina, F., Metellus, P., Intagliata, D., … Loundou, A. (2009). High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas. Acta Neuropathology, 118, 745–754
52. Crispel, Y., Axelman, E., Tatour, M., Kogan, I., Nevo, N., Brenner, B., & Nadir, Y. (2016). Peptides inhibiting heparanase procoagulant activity significantly reduce tumour growth and vascularisation in a mouse model. Thrombosis Haemostasis, 116, 669–678
53. Csoka, A. B., Frost, G. I., & Stern, R. (2001). The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biology, 20, 499–508
54. Cui, D., Sajan, P., Shi, J., Shen, Y., Wang, K., Deng, X., … Gao, L. (2017). MiR-148a increases glioma cell migration and invasion by downregulating GADD45A in human gliomas with IDH1 R132H mutations. Oncotarget, 8, 25345–25361
55. D'Abaco, G. M., & Kaye, A. H. (2007). Integrins: Molecular determinants of glioma invasion. Journal of Clinical Neuroscience, 14, 1041–1048
56. da Fonseca, A. C., Amaral, R., Garcia, C., Geraldo, L. H., Matias, D., & Lima, F. R. (2016). Microglia in cancer: For good or for bad? Advances in Experimental Medicine & Biology, 949, 245–261
57. Datta, S., Pierce, M., & Datta, M. W. (2006). Perlecan signaling: Helping hedgehog stimulate prostate cancer growth. International Journal of Biochemistry & Cell Biology, 38, 1855–1861
58. Davis, F. G., Kupelian, V., Freels, S., McCarthy, B., & Surawicz, T. (2001). Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neuro Oncology, 3, 152–158
59. de Sampaio e Spohr, T. C., Martinez, R., da Silva, E. F., Neto, V. M., & Gomes, F. C. (2002). Neuro-glia interaction effects on GFAP gene: A novel role for transforming growth factor-beta1. European Journal of Neuroscience, 16, 2059–2069
60. DeClerck, Y. A., Mercurio, A. M., Stack, M. S., Chapman, H. A., Zutter, M. M., Muschel, R. J., … Noel, A. (2004). Proteases, extracellular matrix, and cancer: A workshop of the path B study section. American Journal of Pathology, 164, 1131–1139
61. Delpech, B., Laquerriere, A., Maingonnat, C., Bertrand, P., & Freger, P. (2002). Hyaluronidase is more elevated in human brain metastases than in primary brain tumours. Anticancer Research, 22, 2423–2427
62. Denhardt, D. T., Mistretta, D., Chambers, A. F., Krishna, S., Porter, J. F., Raghuram, S., & Rittling, S. R. (2003). Transcriptional regulation of osteopontin and the metastatic phenotype: Evidence for a Ras-activated enhancer in the human OPN promoter. Clinical & Experimental Metastasis, 20, 77–84
63. Depner, C., Zum Buttel, H., Bogurcu, N., Cuesta, A. M., Aburto, M. R., Seidel, S., … Kaulich, K. (2016). EphrinB2 repression through ZEB2 mediates tumour invasion and anti-angiogenic resistance. Nature Communications, 7, 12329
64. Derijck, A. A., Van Erp, S., & Pasterkamp, R. J. (2010). Semaphorin signaling: Molecular switches at the midline. Trends in Cell Biology, 20, 568–576
65. Devine, C. A., & Key, B. (2008). Robo-Slit interactions regulate longitudinal axon pathfinding in the embryonic vertebrate brain. Developmental Biology, 313, 371–383
66. Ding, L., Sun, X., You, Y., Liu, N., & Fu, Z. (2010). Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in human gliomas is associated with unfavorable overall survival. Translational Research, 156, 45–52
67. Dong, C., Mi, R., Jin, G., Zhou, Y., Zhang, J., & Liu, F. (2015). Identification of the proliferative effect of Smad2 and 3 in the TGF β2/Smad signaling pathway using RNA interference in a glioma cell line. Molecular Medicine Reports, 12, 1824–1828
68. Duda, D. G., Kozin, S. V., Kirkpatrick, N. D., Xu, L., Fukumura, D., & Jain, R. K. (2011). CXCL12 (SDF1alpha)-CXCR4/CXCR7 pathway inhibition: An emerging sensitizer for anticancer therapies? Clinical Cancer Research, 17, 2074–2080
69. Duffy, M. J. (1987). Do proteases play a role in cancer invasion and metastasis? European Journal of Cancer and Clinical Oncology, 23, 583–589
70. Dwyer, C. A., Bi, W. L., Viapiano, M. S., & Matthews, R. T. (2014). Brevican knockdown reduces late-stage glioma tumor aggressiveness. Journal of Neurooncology, 120, 63–72
71. Eckerich, C., Zapf, S., Fillbrandt, R., Loges, S., Westphal, M., & Lamszus, K. (2007). Hypoxia can induce c-Met expression in glioma cells and enhance SF/HGF-induced cell migration. International Journal of Cancer, 121, 276–283
72. Ehtesham, M., Mapara, K. Y., Stevenson, C. B., & Thompson, R. C. (2009). CXCR4 mediates the proliferation of glioblastoma progenitor cells. Cancer Letters, 274, 305–312
73. Eisele, G., Wischhusen, J., Mittelbronn, M., Meyermann, R., Waldhauer, I., Steinle, A., … Friese, M. A. (2006). TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells. Brain, 129, 2416–2425
74. El Ayachi, I., Baeza, N., Fernandez, C., Colin, C., Scavarda, D., Pesheva, P., & Figarella-Branger, D. (2010). KIAA0510, the 3′-untranslated region of the tenascin-R gene, and tenascin-R are overexpressed in pilocytic astrocytomas. Neuropathology and Applied Neurobiology, 36, 399–410
75. Elkin, M., Ilan, N., Ishai-Michaeli, R., Friedmann, Y., Papo, O., Pecker, I., & Vlodavsky, I. (2001). Heparanase as mediator of angiogenesis: Mode of action. Faseb Journal, 15, 1661–1663
76. Elstner, A., Holtkamp, N., & von Deimling, A. (2007). Involvement of Hif-1 in desferrioxamine-induced invasion of glioblastoma cells. Clinical and Experimental Metastasis, 24, 57–66
77. Erickson, H. P., & Inglesias, J. L. (1984). A six-armed oligomer isolated from cell surface fibronectin preparations. Nature, 311, 267–269
78. Esencay, M., Sarfraz, Y., & Zagzag, D. (2013). CXCR7 is induced by hypoxia and mediates glioma cell migration towards SDF-1alpha. BMC Cancer, 13, 347
79. Fanjul-Fernández, M., Folgueras, A. R., Cabrera, S., & López-Otín, C. (2010). Matrix metalloproteinases: Evolution, gene regulation and functional analysis in mouse models. Biochimica Biophysica Acta, 1803, 3–19
80. Farin, A., Suzuki, S. O., Weiker, M., Goldman, J. E., Bruce, J. N., & Canoll, P. (2006). Transplanted glioma cells migrate and proliferate on host brain vasculature: A dynamic analysis. Glia, 53, 799–808
81. Felix, K., & Gaida, M. M. (2016). Neutrophil-derived proteases in the microenvironment of pancreatic cancer – Active players in tumor progression. International Journal of Biological Sciences, 12, 302–313
82. Ferluga, S., Tomé, C. M., Herpai, D. M., D'Agostino, R., & Debinski, W. (2016). Simultaneous targeting of Eph receptors in glioblastoma. Oncotarget, 7, 59860–59876
83. Fernández-Vega, I., García-Suárez, O., García, B., Crespo, A., Astudillo, A., & Quirós, L. M. (2015). Heparan sulfate proteoglycans undergo differential expression alterations in right sided colorectal cancer, depending on their metastatic character. BMC Cancer, 15, 742
84. Ferrer, V. P., de Mari, T. L., Gremski, L. H., Trevisan Silva, D., da Silveira, R. B., Gremski, W., … Veiga, S. S. (2013). A novel hyaluronidase from brown spider (Loxosceles intermedia) venom (Dietrich's Hyaluronidase): From cloning to functional characterization. PLOS Neglected Tropical Diseases, 7, e2206
85. Franco, C., Patricia, H. R., Timo, S., Claudia, B., & Marcela, H. (2017). Matrix metalloproteinases as regulators of periodontal inflammation. International Journal of Molecular Sciences, 18, 440
86. Franzmann, E. J., Schroeder, G. L., Goodwin, W. J., Weed, D. T., Fisher, P., & Lokeshwar, V. B. (2003). Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors. International Journal of Cancer, 106, 438–445
87. Frei, K., Gramatzki, D., Tritschler, I., Schroeder, J. J., Espinoza, L., Rushing, E. J., & Weller, M. (2015). Transforming growth factor-beta pathway activity in glioblastoma. Oncotarget, 6, 5963–5977
88. Friedlander, D. R., Zagzag, D., Shiff, B., Cohen, H., Allen, J. C., Kelly, P. J., & Grumet, M. (1996). Migration of brain tumor cells on extracellular matrix proteins in vitro correlates with tumor type and grade and involves alphaV and beta1 integrins. Cancer Research, 56, 1939–1947
89. Frischknecht, R., & Seidenbecher, C. I. (2008). The crosstalk of hyaluronan-based extracellular matrix and synapses. Neuron Glia Biology, 4, 249–257
90. Fu, Y., Ponce, M. L., Thill, M., Yuan, P., Wang, N. S., & Csaky, K. G. (2007). Angiogenesis inhibition and choroidal neovascularization suppression by sustained delivery of an integrin antagonist, EMD478761. Investigative Ophthalmology & Visual Science, 48, 5184–5190
91. Fujisawa, H. (2004). Discovery of semaphorin receptors, neuropilin and plexin, and their functions in neural development. Journal of Neurobiology, 59, 24–33
92. Fukushima, K., Ueno, Y., Inoue, J., Kanno, N., & Shimosegawa, T. (2006). Filopodia formation via a specific Eph family member and PI3K in immortalized cholangiocytes. American Journal of Physiology-Gastrointestinal Liver Physiology, 291, G812–G819
93. Fukushima, Y., Ohnishi, T., Arita, N., Hayakawa, T., & Sekiguchi, K. (1998). Integrin alpha3beta1-mediated interaction with laminin-5 stimulates adhesion, migration and invasion of malignant glioma cells. International Journal of Cancer, 76, 63–72
94. Gagliardi, F., Narayanan, A., Reni, M., Franzin, A., Mazza, E., Boari, N., … Mortini, P. (2014). The role of CXCR4 in highly malignant human gliomas biology: Current knowledge and future directions. Glia, 62, 1015–1023
95. Gary, S. C., & Hockfield, S. (2000). BEHAB/brevican: An extracellular matrix component associated with invasive glioma. Clinical Neurosurgery, 47, 72–82
96. Gatti, M., Pattarozzi, A., Bajetto, A., Wurth, R., Daga, A., Fiaschi, P., … Barbieri, F. (2013). Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity. Toxicology, 314, 209–220
97. Gerstner, E. R., Ye, X., Duda, D. G., Levine, M. A., Mikkelsen, T., Kaley, T. J., … Wen, P. Y. (2015). A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastoma. Neuro Oncology, 17, 1386–1392
98. Giusti, I., Delle Monache, S., Di Francesco, M., Sanita, P., D'Ascenzo, S., Gravina, G. L., … Dolo, V. (2016). From glioblastoma to endothelial cells through extracellular vesicles: Messages for angiogenesis. Tumour Biology, 37, 12743–12753
99. Gladson, C. L. (1996). Expression of integrin alpha v beta 3 in small blood vessels of glioblastoma tumors. Journal of Neuropathology & Experimental Neurology, 55, 1143–1149
100. Godlewski, J., Bronisz, A., Nowicki, M. O., Chiocca, E. A., & Lawler, S. (2010a). microRNA-451: A conditional switch controlling glioma cell proliferation and migration. Cell Cycle, 9, 2742–2748
101. Godlewski, J., Nowicki, M. O., Bronisz, A., Nuovo, G., Palatini, J., D., Lay, M., Van Brocklyn, J., … Lawler, S. E. (2010b). MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Molecular Cell, 37, 620–632
102. Goldshmidt, O., Zcharia, E., Cohen, M., Aingorn, H., Cohen, I., Nadav, L., … Vlodavsky, I. (2003). Heparanase mediates cell adhesion independent of its enzymatic activity. Faseb J, 17, 1015–1025
103. Gouëffic, Y., Guilluy, C., Guérin, P., Patra, P., Pacaud, P., & Loirand, G. (2006). Hyaluronan induces vascular smooth muscle cell migration through RHAMM-mediated PI3K-dependent Rac activation. Cardiovascular Research, 72, 339–348
104. Gould, C. M., & Courtneidge, S. A. (2014). Regulation of invadopodia by the tumor microenvironment. Cell Adhesion & Migration, 8, 226–235
105. Graeber, M. B., Scheithauer, B. W., & Kreutzberg, G. W. (2002). Microglia in brain tumors. Glia, 40, 252–259
106. Gu, C., & Giraudo, E. (2013). The role of semaphorins and their receptors in vascular development and cancer. Experimental Cell Research, 319, 1306–1316
107. Gu, C., Limberg, B. J., Whitaker, G. B., Perman, B., Leahy, D. J., Rosenbaum, J. S., … Kolodkin, A. L. (2002). Characterization of neuropilin-1 structural features that confer binding to semaphorin 3A and vascular endothelial growth factor 165. Journal of Biological Chemistry, 277, 18069–18076
108. Guan, J. L. (2010). Integrin signaling through FAK in the regulation of mammary stem cells and breast cancer. IUBMB Life, 62, 268–276
109. Gupta, A. K., Bakanauskas, V. J., Cerniglia, G. J., Cheng, Y., Bernhard, E. J., Muschel, R. J., & McKenna, W. G. (2001). The Ras radiation resistance pathway. Cancer Research, 61, 4278–4282
110. Gurski, L. A., Xu, X., Labrada, L. N., Nguyen, N. T., Xiao, L., van Golen, K. L., … Farach-Carson, M. C. (2012). Hyaluronan (HA) interacting proteins RHAMM and hyaluronidase impact prostate cancer cell behavior and invadopodia formation in 3D HA-based hydrogels. PLoS One, 7, e50075
111. Hall, C. L., Collis, L. A., Bo, A. J., Lange, L., McNicol, A., Gerrard, J. M., & Turley, E. A. (2001). Fibroblasts require protein kinase C activation to respond to hyaluronan with increased locomotion. Matrix Biology, 20, 183–192
112. Hardee, M. E., & Zagzag, D. (2012). Mechanisms of glioma-associated neovascularization. American Journal of Pathology, 181, 1126–1141
113. Hardwick, C., Hoare, K., Owens, R., Hohn, H. P., Hook, M., Moore, D., … Turley, E. A. (1992). Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. Journal of Cell Biology, 117, 1343–1350
114. Harisi, R., & Jeney, A. (2015). Extracellular matrix as target for antitumor therapy. Onco Targets Therapy, 8, 1387–1398
115. Hattermann, K., Gebhardt, H., Krossa, S., Ludwig, A., Lucius, R., Held-Feindt, J., & Mentlein, R. (2016). Transmembrane chemokines act as receptors in a novel mechanism termed inverse signaling. Elife, 5, e10820
116. Hattermann, K., Held-Feindt, J., Lucius, R., Müerköster, S. S., Penfold, M. E., Schall, T. J., & Mentlein, R. (2010). The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects. Cancer Research, 70, 3299–3308
117. Hattermann, K., Held-Feindt, J., Ludwig, A., & Mentlein, R. (2013). The CXCL16-CXCR6 chemokine axis in glial tumors. Journal of Neuroimmunology, 260, 47–54
118. Hattermann, K., & Mentlein, R. (2013). An infernal trio: The chemokine CXCL12 and its receptors CXCR4 and CXCR7 in tumor biology. Annals of Anatomy, 195, 103–110
119. Hattermann, K., & Mentlein, R. (2014). Para- and autocrine mediators in the glioma microenvironment. In: Sedo A, Mentlein R, editors. Glioma Cell Biology. New York, Dordrecht, London: Springer-Vienna. p 153–85.
120. Hau, P., Jachimczak, P., Schlaier, J., & Bogdahn, U. (2011). TGF-β2 signaling in high-grade gliomas. Current Pharmaceutical Biotechnology, 12, 2150–2157
121. Held-Feindt, J., Paredes, E. B., Blomer, U., Seidenbecher, C., Stark, A. M., Mehdorn, H. M., & Mentlein, R. (2006). Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas. International Journal of Cancer, 118, 55–61
122. Herold-Mende, C., Mueller, M. M., Bonsanto, M. M., Schmitt, H. P., Kunze, S., & Steiner, H. H. (2002). Clinical impact and functional aspects of tenascin-C expression during glioma progression. International Journal of Cancer, 98, 362–369
123. Hirai, H., Maru, Y., Hagiwara, K., Nishida, J., & Takaku, F. (1987). A novel putative tyrosine kinase receptor encoded by the eph gene. Science, 238, 1717–1720
124. Hirata, E., Arakawa, Y., Shirahata, M., Yamaguchi, M., Kishi, Y., Okada, T., … Hashimoto, N. (2009). Endogenous tenascin-C enhances glioblastoma invasion with reactive change of surrounding brain tissue. Cancer Science, 100, 1451–1459
125. Holland, E. C., Celestino, J., Dai, C., Schaefer, L., Sawaya, R. E., & Fuller, G. N. (2000). Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nature Genetics, 25, 55–57
126. Hong, X., Jiang, F., Kalkanis, S. N., Zhang, Z. G., Zhang, X., Zheng, X., … Chopp, M. (2008). Increased chemotactic migration and growth in heparanase-overexpressing human U251n glioma cells. Journal of Experimental & Clinical Cancer Research, 27, 23
127. Hong, X., Jiang, F., Kalkanis, S. N., Zhang, Z. G., Zhang, X. P., deCarvalho, A. C., … Chopp, M. (2006). SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion. Cancer Letters, 236, 39–45
128. Hong, X., Nelson, K. K., deCarvalho, A. C., & Kalkanis, S. N. (2010). Heparanase expression of glioma in human and animal models. Journal of Neurosurgery, 113, 261–269
129. Hottinger, A. F., Aissa, A. B., Espeli, V., Squiban, D., Dunkel, N., Vargas, M. I., … Weber, D. C. (2014). Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma. British Journal of Cancer, 110, 2655–2661
130. Howell, M. D., & Gottschall, P. E. (2012). Lectican proteoglycans, their cleaving metalloproteinases, and plasticity in the central nervous system extracellular microenvironment. Neuroscience, 217, 6–18
131. Hsieh, H. L., Wang, H. H., Wu, W. B., Chu, P. J., & Yang, C. M. (2010). Transforming growth factor-beta1 induces matrix metalloproteinase-9 and cell migration in astrocytes: Roles of ROS-dependent ERK- and JNK-NF-kappaB pathways. Journal of Neuroinflammation, 7, 88
132. Hu, B., Kong, L. L., Matthews, R. T., & Viapiano, M. S. (2008). The proteoglycan brevican binds to fibronectin after proteolytic cleavage and promotes glioma cell motility. Journal of Biological Chemistry, 283, 24848–24859
133. Hu, F., Ku, M. C., Markovic, D., A Dzaye, O. D., Lehnardt, S., Synowitz, M., … Kettenmann, H. (2014). Glioma-associated microglial MMP9 expression is upregulated by TLR2 signaling and sensitive to minocycline. International Journal of Cancer, 135, 2569–2578
134. Hu, Y., & Tang, H. (2014). MicroRNAs regulate the epithelial to mesenchymal transition (EMT) in cancer progression. MicroRNA, 3, 108–117
135. Huang, W. J., Chen, W. W., & Zhang, X. (2016). Glioblastoma multiforme: Effect of hypoxia and hypoxia inducible factors on therapeutic approaches. Oncol Letters, 12, 2283–2288
136. Hwang, S. Y., Yoo, B. C., Jung, J. W., Oh, E. S., Hwang, J. S., Shin, J. A., … Han, I. O. (2009). Induction of glioma apoptosis by microglia-secreted molecules: The role of nitric oxide and cathepsin B. Biochimica Biophysica Acta, 1793, 1656–1668
137. Hynes, R. O. (1987). Integrins: A family of cell surface receptors. Cell, 48, 549–554
138. Imanaka-Yoshida, K., & Aoki, H. (2014). Tenascin-C and mechanotransduction in the development and diseases of cardiovascular system. Frontiers in Physiology, 5, 283
139. Inoue, S., Ichikawa, T., Kurozumi, K., Maruo, T., Onishi, M., Yoshida, K., … Date, I. (2012). Novel animal glioma models that separately exhibit two different invasive and angiogenic phenotypes of human glioblastomas. World Neurosurgery, 78, 670–682
140. Iozzo, R. V., & Cohen, I. (1994). Altered proteoglycan gene expression and the tumor stroma. EXS, 70, 199–214
141. Iozzo, R. V., & Schaefer, L. (2015). Proteoglycan form and function: A comprehensive nomenclature of proteoglycans. Matrix Biology, 42, 11–55
142. Iser, I. C., Pereira, M. B., Lenz, G., & Wink, M. R. (2017). The epithelial-to-mesenchymal transition-like process in glioblastoma: An updated systematic review and in silico investigation. Medicinal Research Version, 37, 271–313
143. Itano, N., Zhuo, L., & Kimata, K. (2008). Impact of the hyaluronan-rich tumor microenvironment on cancer initiation and progression. Cancer Science, 99, 1720–1725
144. Ivanoff, J., Talme, T., & Sundqvist, K. G. (2005). The role of chemokines and extracellular matrix components in the migration of T lymphocytes into three-dimensional substrata. Immunology, 114, 53–62
145. Ivkovic, S., Beadle, C., Noticewala, S., Massey, S. C., Swanson, K. R., Toro, L. N., … Rosenfeld, S. S. (2012). Direct inhibition of myosin II effectively blocks glioma invasion in the presence of multiple motogens. Molecular Biology of the Cell, 23, 533–542
146. Iwadate, Y. (2016). Epithelial-mesenchymal transition in glioblastoma progression. Oncology Letters, 11, 1615–1620
147. Iwatsuki, M., Mimori, K., Yokobori, T., Ishi, H., Beppu, T., Nakamori, S., … Mori, M. (2010). Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Science, 101, 293–299
148. Jakubowicz-Gil, J., Bądziul, D., Langner, E., Wertel, I., Zając, A., & Rzeski, W. (2017). Temozolomide and sorafenib as programmed cell death inducers of human glioma cells. Pharmacological Reports, 69, 779–787
149. Janssen, B. J., Malinauskas, T., Weir, G. A., Cader, M. Z., Siebold, C., & Jones, E. Y. (2012). Neuropilins lock secreted semaphorins onto plexins in a ternary signaling complex. Nature Structural & Molecular Biology, 19, 1293–1299
150. Jarjour, A. A., Durko, M., Luk, T. L., Marcal, N., Shekarabi, M., & Kennedy, T. E. (2011). Autocrine netrin function inhibits glioma cell motility and promotes focal adhesion formation. PLoS One, 6, e25408
151. Jin, S. G., Jeong, Y. I., Jung, S., Ryu, H. H., Jin, Y. H., & Kim, I. Y. (2009). The effect of hyaluronic acid on the invasiveness of malignant glioma cells: Comparison of invasion potential at hyaluronic Acid hydrogel and matrigel. Journal of Korean Neurosurgical Society, 46, 472–478
152. Jordan, A. R., Racine, R. R., Hennig, M. J., & Lokeshwar, V. B. (2015). The role of CD44 in disease pathophysiology and targeted treatment. Frontiers in Immunology, 6, 182
153. Josefsson, A., Adamo, H., Hammarsten, P., Granfors, T., Stattin, P., Egevad, L., … Bergh, A. (2011). Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcome. American Journal of Pathology, 179, 1961–1968
154. Joseph, J. V., Balasubramaniyan, V., Walenkamp, A., & Kruyt, F. A. (2013). TGF-β as a therapeutic target in high grade gliomas – Promises and challenges. Biochemical Pharmacology, 85(4), 478–485. Feb 15
155. Joseph, J. V., Conroy, S., Pavlov, K., Sontakke, P., Tomar, T., Eggens-Meijer, E., … Kruyt, F. A. (2015). Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1alpha-ZEB1 axis. Cancer Letters, 359, 107–116
156. Joseph, J. V., Conroy, S., Tomar, T., Eggens-Meijer, E., Bhat, K., Copray, S., … Kruyt, F. A. (2014). TGF-beta is an inducer of ZEB1-dependent mesenchymal transdifferentiation in glioblastoma that is associated with tumor invasion. Cell Death & Disease, 5, e1443
157. Junker, N., Latini, S., Petersen, L. N., & Kristjansen, P. E. (2003). Expression and regulation patterns of hyaluronidases in small cell lung cancer and glioma lines. Oncology Reports, 10, 609–616
158. Kahlert, U. D., Maciaczyk, D., Doostkam, S., Orr, B. A., Simons, B., Bogiel, T., … Maciaczyk, J. (2012). Activation of canonical WNT/beta-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition. Cancer Letters, 325, 42–53
159. Kahlert, U. D., Nikkhah, G., & Maciaczyk, J. (2013). Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas. Cancer Letters, 331, 131–138
160. Kahn, S. A., Biasoli, D., Garcia, C., Geraldo, L. H., Pontes, B., Sobrinho, M. … Others, (2012). Equinatoxin II potentiates temozolomide- and etoposide-induced glioblastoma cell death. Current Topics in Medicinal Chemistry, 12, 2082–2093
161. Kalembeyi, I., Inada, H., Nishiura, R., Imanaka-Yoshida, K., Sakakura, T., & Yoshida, T. (2003). Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: Direct and synergistic effects with transforming growth factor beta1. International Journal of Cancer, 105, 53–60
162. Kalluri, R., & Weinberg, R. A. (2009). The basics of epithelial-mesenchymal transition. Journal of Clinical Investigation, 119, 1420–1428
163. Kaminska, B., Kocyk, M., & Kijewska, M. (2013). TGF beta signaling and its role in glioma pathogenesis. Advances in Experimental Medicine and Biology, 986, 171–187
164. Karajannis, M. A., Legault, G., Fisher, M. J., Milla, S. S., Cohen, K. J., Wisoff, J. H., … Merkelson, A. (2014). Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas. Neuro Oncology, 16, 1408–1416
165. Karayan-Tapon, L., Wager, M., Guilhot, J., Levillain, P., Marquant, C., Clarhaut, J., … Roche, J. (2008). Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker? British Journal of Cancer, 99, 1153–1160
166. Kargiotis, O., Rao, J. S., & Kyritsis, A. P. (2006). Mechanisms of angiogenesis in gliomas. Journal of Neurooncology, 78, 281–293
167. Karousou, E., Misra, S., Ghatak, S., Dobra, K., Gotte, M., Vigetti, D., … Skandalis, S. S. (2017). Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer. Matrix Biology, 59, 3–22
168. Kast, R. E., & Halatsch, M. E. (2012). Matrix metalloproteinase-2 and −9 in glioblastoma: A trio of old drugs-captopril, disulfiram and nelfinavir-are inhibitors with potential as adjunctive treatments in glioblastoma. Archives of Medical Research, 43, 243–247
169. Kast, R. E., Ramiro, S., Lladó, S., Toro, S., Coveñas, R., & Muñoz, M. (2016). Antitumor action of temozolomide, ritonavir and aprepitant against human glioma cells. Journal of Neurooncology, 126, 425–431
170. Kenig, S., Alonso, M. B., Mueller, M. M., & Lah, T. T. (2010). Glioblastoma and endothelial cells cross-talk, mediated by SDF-1, enhances tumour invasion and endothelial proliferation by increasing expression of cathepsins B, S, and MMP-9. Cancer Letters, 289, 53–61
171. Kessenbrock, K., Plaks, V., & Werb, Z. (2010). Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell, 141, 52–67
172. Kim, C. S., Jung, S., Jung, T. Y., Jang, W. Y., Sun, H. S., & Ryu, H. H. (2011). Characterization of invading glioma cells using molecular analysis of leading-edge tissue. Journal of Korean Neurosurgical Society, 50, 157–165
173. Kim, M. S., Park, M. J., Kim, S. J., Lee, C. H., Yoo, H., Shin, S. H., … Lee, S. H. (2005). Emodin suppresses hyaluronic acid-induced MMP-9 secretion and invasion of glioma cells. International Journal of Oncology, 27, 839–846
174. Kim, S. J., Park, J. W., Yoon, J. S., Mok, J. O., Kim, Y. J., Park, H. K., … Jin, S. Y. (2004). Increased expression of focal adhesion kinase in thyroid cancer: Immunohistochemical study. Journal of Korean Medical Sciences, 19, 710–715
175. Kim, Y., & Kumar, S. (2014). CD44-mediated adhesion to hyaluronic acid contributes to mechanosensing and invasive motility. Molecular Cancer Research, 12, 1416–1429
176. Kim, Y., Lee, Y. S., Choe, J., Lee, H., Kim, Y. M., & Jeoung, D. (2008). CD44-epidermal growth factor receptor interaction mediates hyaluronic acid-promoted cell motility by activating protein kinase C signaling involving Akt, Rac1, Phox, reactive oxygen species, focal adhesion kinase, and MMP-2. Journal of Biological Chemistry, 283, 22513–22528
177. Klank, R. L., Decker Grunke, S. A., Bangasser, B. L., Forster, C. L., Price, M. A., Odde, T. J., SantaCruz, K. S., Rosenfeld, S. S., Canoll, P. (2017). Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression Level. Cell Reports, 19, 668
178. Kleihues, P., & Sobin, L. H. (2000). World Health Organization classification of tumors. Cancer, 88, 2887
179. Knott, J. C., Mahesparan, R., Garcia-Cabrera, I., Bølge Tysnes, B., Edvardsen, K., Ness, G. O., … Bjerkvig, R. (1998). Stimulation of extracellular matrix components in the normal brain by invading glioma cells. International Journal of Cancer, 75, 864–872
180. Kochlamazashvili, G., Henneberger, C., Bukalo, O., Dvoretskova, E., Senkov, O., Lievens, P. M., … Rusakov, D. A. (2010). The extracellular matrix molecule hyaluronic acid regulates hippocampal synaptic plasticity by modulating postsynaptic L-type Ca(2+) channels. Neuron, 67, 116–128
181. Komatani, H., Sugita, Y., Arakawa, F., Ohshima, K., & Shigemori, M. (2009). Expression of CXCL12 on pseudopalisading cells and proliferating microvessels in glioblastomas: An accelerated growth factor in glioblastomas. International Journal of Oncology, 34, 665–672
182. Komori, T. (2017). The 2016 WHO classification of tumours of the central nervous system: The major points of revision. Neurologia Medico Chirurgica (Tokyo), 57, 301–311
183. Kong, Q. Y., Liu, J., Chen, X. Y., Wang, X. W., Sun, Y., & Li, H. (2003). Differential expression patterns of hyaluronan receptors CD44 and RHAMM in transitional cell carcinomas of urinary bladder. Oncology Reports, 10, 51–55
184. Kong, X., Li, G., Yuan, Y., He, Y., Wu, X., Zhang, W. … Others, (2012). MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression. PLoS One, 7, e41523
185. Kreisl, T. N., Kim, L., Moore, K., Duic, P., Royce, C., Stroud, I., … Camphausen, K. (2009). Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. Journal of Clinical Oncology, 27, 740–745
186. Krstic, J., & Santibanez, J. F. (2014). Transforming growth factor-beta and matrix metalloproteinases: Functional interactions in tumor stroma-infiltrating myeloid cells. Scientific World Journal, 2014, 521754
187. Krusche, B., Ottone, C., Clements, M. P., Johnstone, E. R., Goetsch, K., Lieven, H., … Ashraf, A. (2016). EphrinB2 drives perivascular invasion and proliferation of glioblastoma stem-like cells. eLife, 5, e14845
188. Kucharzewska, P., Christianson, H. C., Welch, J. E., Svensson, K. J., Fredlund, E., Ringner, M., … Belting, M. (2013). Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proceedings of the National Academy of Sciences of the United States of America, 110, 7312–7317
189. Kultti, A., Li, X., Jiang, P., Thompson, C. B., Frost, G. I., & Shepard, H. M. (2012). Therapeutic targeting of hyaluronan in the tumor stroma. Cancers (Basel), 4, 873–903
190. Kundu, S., Xiong, A., Spyrou, A., Wicher, G., Marinescu, V. D., Edqvist, P. D., … Smits, A. (2016). Heparanase promotes glioma progression and is inversely correlated with patient survival. Molecular Cancer Research, 14, 1243–1253
191. Kwiatkowska, A., & Symons, M. (2013). Signaling determinants of glioma cell invasion. Advances in Experimental Medicine and Biology, 986, 121–141
192. Lai, I. R., Chu, P. Y., Lin, H. S., Liou, J. Y., Jan, Y. J., Lee, J. C., & Shen, T. L. (2010). Phosphorylation of focal adhesion kinase at Tyr397 in gastric carcinomas and its clinical significance. American Journal of Pathology, 177, 1629–1637
193. Lakka, S. S., Gondi, C. S., & Rao, J. S. (2005). Proteases and glioma angiogenesis. Brain Pathology, 15, 327–341
194. Lal, S., Kersch, C., Beeson, K. A., Wu, Y. J., Muldoon, L. L., & Neuwelt, E. A. (2015). Interactions between alphav-Integrin and HER2 and their role in the invasive phenotype of breast cancer cells in vitro and in rat brain. PLoS One, 10, e0131842
195. Lamanna, W. C., Frese, M. A., Balleininger, M., & Dierks, T. (2008). Sulf loss influences N-, 2-O-, and 6-O-sulfation of multiple heparan sulfate proteoglycans and modulates fibroblast growth factor signaling. Journal of Biological Chemistry, 283, 27724–27735
196. Lamouille, S., Xu, J., & Derynck, R. (2014). Molecular mechanisms of epithelial-mesenchymal transition. Nature Reviews Molecular Cell Biology, 15, 178–196
197. Law, J. W., & Lee, A. Y. (2012). The role of semaphorins and their receptors in gliomas. Journal of Signal Transduction, 2012, 902854
198. Lazennec, G., & Richmond, A. (2010). Chemokines and chemokine receptors: New insights into cancer-related inflammation. Trends in Molecular Medicine, 16, 12
199. Lee, J. K., Joo, K. M., Lee, J., Yoon, Y., & Nam, D. H. (2014). Targeting the epithelial to mesenchymal transition in glioblastoma: The emerging role of MET signaling. OncoTargets and Therapy, 7, 1933–1944
200. Lelongt, B., Piedagnel, R., Chatelet, F., Baudouin, B., Brenchley, P. E., Verroust, P. J., … Ronco, P. M. (1992). Dramatic changes of sulfated proteoglycans composition in a tumorigenic SV-40-transformed renal proximal-tubule cell line. Journal of Biological Chemistry, 267, 23815–23822
201. Lettau, I., Hattermann, K., Held-Feindt, J., Brauer, R., Sedlacek, R., & Mentlein, R. (2010). Matrix metalloproteinase-19 is highly expressed in astroglial tumors and promotes invasion of glioma cells. Journal of Neuropathology & Experimental Neurology, 69, 215–223
202. Levicar, N., Nuttall, R. K., & Lah, T. T. (2003). Proteases in brain tumour progression. Acta Neurochirurgica (Wien), 145, 825–838
203. Li, Y., Ali, S., Clarke, J., & Cha, S. (2017). Bevacizumab in recurrent glioma: Patterns of treatment failure and implications. Brain Tumor Research and Treatment, 5, 1–9
204. Liao, A., Shi, R., Jiang, Y., Tian, S., Li, P., Song, F., … Yang, X. (2016). SDF-1/CXCR4 axis regulates cell cycle progression and epithelial-mesenchymal transition via up-regulation of survivin in glioblastoma. Molecular Neurobiology, 53, 210–215
205. Lin, H. C., Hsieh, H. M., Chen, Y. H., & Hu, M. L. (2009). S-Adenosylhomocysteine increases beta-amyloid formation in BV-2 microglial cells by increased expressions of beta-amyloid precursor protein and presenilin 1 and by hypomethylation of these gene promoters. Neurotoxicology, 30, 622–627
206. Li, Q., Cheng, Q., Chen, Z., Peng, R., Chen, R., Ma, Z., … Jiang, B. (2016). MicroRNA-663 inhibits the proliferation, migration and invasion of glioblastoma cells via targeting TGF-beta1. Oncology Reports, 35, 1125–1134
207. Liu, S. (2009). Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: Maximizing binding affinity via bivalency. Bioconjugate Chemistry, 20, 2199–2213
208. Liu, T. J., LaFortune, T., Honda, T., Ohmori, O., Hatakeyama, S., Meyer, T., … Yung, W. K. (2007). Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo. Molecular Cancer Therapeutics, 6, 1357–1367
209. Lokeshwar, V. B., Cerwinka, W. H., Isoyama, T., & Lokeshwar, B. L. (2005). HYAL1 hyaluronidase in prostate cancer: A tumor promoter and suppressor. Cancer Research, 65, 7782–7789
210. Lokeshwar, V. B., Fregien, N., & Bourguignon, L. Y. (1994). Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function. Journal of Cell Biology, 126, 1099–1109
211. Lokeshwar, V. B., Mirza, S., & Jordan, A. (2014). Targeting hyaluronic acid family for cancer chemoprevention and therapy. Advances in Cancer Research, 123, 35–65
212. Lokeshwar, V. B., Schroeder, G. L., Carey, R. I., Soloway, M. S., & Iida, N. (2002). Regulation of hyaluronidase activity by alternative mRNA splicing. Journal of Biological Chemistry, 277, 33654–33663
213. Lopez-Otin, C., & Bond, J. S. (2008). Proteases: Multifunctional enzymes in life and disease. Journal of Biological Chemistry, 283, 30433–30437
214. Louis, D. N. (2006). Molecular pathology of malignant gliomas. Annual Review of Pathology, 1, 97–117
215. Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., … Kleihues, P. (2007). The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathology, 114, 97–109
216. Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., … Ellison, D. W. (2016). The 2016 World Health Organization classification of tumors of the central nervous system: A summary. Acta Neuropathology, 131, 803–820
217. Lu, P., Takai, K., Weaver, V. M., & Werb, Z. (2011). Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harbor Perspectives Biology, 3.
218. MacDonald, T. J., Taga, T., Shimada, H., Tabrizi, P., Zlokovic, B. V., Cheresh, D. A., & Laug, W. E. (2001). Preferential susceptibility of brain tumors to the antiangiogenic effects of an alpha(v) integrin antagonist. Neurosurgery, 48, 151–157
219. Maeda, N. (2015). Proteoglycans and neuronal migration in the cerebral cortex during development and disease. Frontiers in Neuroscience, 9, 98
220. Mahabir, R., Tanino, M., Elmansuri, A., Wang, L., Kimura, T., Itoh, T., … Tanaka, S. (2014). Sustained elevation of Snail promotes glial-mesenchymal transition after irradiation in malignant glioma. Neuro-oncology, 16, 671–668
221. Maherally, Z., Smith, J. R., Ghoneim, M. K., Dickson, L., An, Q., Fillmore, H. L., & Pilkington, G. J. (2016). Silencing of CD44 in glioma leads to changes in cytoskeletal protein expression and cellular biomechanical deformation properties as measured by AFM nanoindentation. BioNanoScience, 6, 54–64
222. Malipiero, U., Holler, M., Werner, U., & Fontana, A. (1990). Sequence analysis of the promoter region of the glioblastoma derived T cell suppressor factor/transforming growth factor (TGF)-beta 2 gene reveals striking differences to the TGF-beta 1 and -beta 3 genes. Biochemical and Biophysical Research Communications, 171, 1145–1151
223. Mancino, M., Ametller, E., Gascon, P., & Almendro, V. (2011). The neuronal influence on tumor progression. Biochimica Biophysica Acta, 1816, 105–118
224. Mani, S. A., Guo, W., Liao, M. J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., … Shipitsin, M. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 133, 704–715
225. Mantovani, A., Bonecchi, R., & Locati, M. (2006). Tuning inflammation and immunity by chemokine sequestration: Decoys and more. Nature Reviews Immunology, 6, 907–918
226. Maris, C., Rorive, S., Sandras, F., D'Haene, N., Sadeghi, N., Bieche, I., … Salmon, I. (2008). Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas. Neuropathology and Applied Neurobiology, 34, 316–329
227. Martens, T., Schmidt, N. O., Eckerich, C., Fillbrandt, R., Merchant, M., Schwall, R., … Lamszus, K. (2006). A novel one-armed anti-c-Met antibody inhibits glioblastoma growth in vivo. Clinical Cancer Research, 12, 6144–6152
228. Martins-Green, M., Petreaca, M., & Wang, L. (2013). Chemokines and their receptors are key players in the orchestra that regulates wound healing. Advances in Wound Care (New Rochelle), 2, 327–347
229. Mascaro, M., Pibuel, M. A., Lompardia, S. L., Diaz, M., Zotta, E., Bianconi, M. I., … Alvarez, E. (2017). Low molecular weight hyaluronan induces migration of human choriocarcinoma JEG-3 cells mediated by RHAMM as well as by PI3K and MAPK pathways. Histochemistry and Cell Biology, 148, 173–187
230. Matias, D., Balça-Silva, J., Dubois, L. G., Pontes, B., Ferrer, V. P., Rosario, L., … Lopes, M. C. (2017). Dual treatment with shikonin and temozolomide reduces glioblastoma tumor growth, migration and glial-to-mesenchymal transition. Cell Oncology (Dordr), 40, 247–261
231. Mawrin, C., & Seidenbecher, C. (2014). Glioma and extracellular matrix. Glioma Cell Biology, 271–292
232. Maxwell, C. A., McCarthy, J., & Turley, E. (2008). Cell-surface and mitotic-spindle RHAMM: Moonlighting or dual oncogenic functions? Journal of Cell Science, 121, 925–932
233. McCarter, J. D., & Withers, S. G. (1994). Mechanisms of enzymatic glycoside hydrolysis. Current Opinion in Structural Biology, 4, 885–892
234. McMillen, P., & Holley, S. A. (2015). Integration of cell-cell and cell-ECM adhesion in vertebrate morphogenesis. Current Opinion in Cell Biology, 36, 48–53
235. Melo, C. M., Tersariol, I. L., Nader, H. B., Pinhal, M. A., & Lima, M. A. (2015). Development of new methods for determining the heparanase enzymatic activity. Carbohydrate Research, 412, 66–70
236. Mentlein, R., Hattermann, K., & Held-Feindt, J. (2012). Lost in disruption: Role of proteases in glioma invasion and progression. Biochimica Biophysica Acta, 1825, 178–185
237. Miao, H., Wei, B. R., Peehl, D. M., Li, Q., Alexandrou, T., Schelling, J. R., … Wang, B. (2001). Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway. Nature Cell Biology, 3, 527–530
238. Midwood, K. S., & Orend, G. (2009). The role of tenascin-C in tissue injury and tumorigenesis. Journal of Cell Communication and Signaling, 3, 287–310
239. Misra, S., Ghatak, S., Patil, N., Dandawate, P., Ambike, V., Adsule, S., … Padhye, S. (2013). Novel dual cyclooxygenase and lipoxygenase inhibitors targeting hyaluronan-CD44v6 pathway and inducing cytotoxicity in colon cancer cells. Bioorganic & Medicinal Chemistry, 21, 2551–2559
240. Misra, S., Hascall, V. C., Markwald, R. R., & Ghatak, S. (2015). Interactions between Hyaluronan and Its receptors (CD44, RHAMM) regulate the activities of inflammation and cancer. Frontiers in Immunology, 6, 201
241. Mittelbronn, M., Warth, A., Meyermann, R., Goodman, S., & Weller, M. (2013). Expression of integrins alphavbeta3 and alphavbeta5 and their ligands in primary and secondary central nervous system neoplasms. Histology and Histopathology, 28, 749–758
242. Montell, D. J. (2001). Command and control: Regulatory pathways controlling invasive behavior of the border cells. Mechanisms of Development, 105, 19–25
243. Mooney, K. L., Choy, W., Sidhu, S., Pelargos, P., Bui, T. T., Voth, B., … Yang, I. (2016). The role of CD44 in glioblastoma multiforme. Journal of Clinical Neuroscience, 34, 1–5
244. Mukaida, N., Sasaki, S., & Baba, T. (2014). Chemokines in cancer development and progression and their potential as targeting molecules for cancer treatment. Mediators of Inflammation, 2014, 170381
245. Murakami, D., Okamoto, I., Nagano, O., Kawano, Y., Tomita, T., Iwatsubo, T., … Saya, H. (2003). Presenilin-dependent gamma-secretase activity mediates the intramembranous cleavage of CD44. Oncogene, 22, 1511–1516
246. Murphy, D. A., & Courtneidge, S. A. (2011). The 'ins' and 'outs' of podosomes and invadopodia: Characteristics, formation and function. Nature Reviews Molecular Cell Biology, 12, 413–426
247. Murray, D. W., Didier, S., Chan, A., Paulino, V., Van Aelst, L., Ruggieri, R., … Symons, M. (2014). Guanine nucleotide exchange factor Dock7 mediates HGF-induced glioblastoma cell invasion via Rac activation. British Journal of Cancer, 110, 1307–1315
248. Musumeci, G., Magro, G., Cardile, V., Coco, M., Marzagalli, R., Castrogiovanni, P., … Di Rosa, M. (2015). Characterization of matrix metalloproteinase-2 and −9, ADAM-10 and N-cadherin expression in human glioblastoma multiforme. Cell and Tissue Research, 362, 45–60
249. Muthana, S. M., Campbell, C. T., & Gildersleeve, J. C. (2012). Modifications of glycans: Biological significance and therapeutic opportunities. ACS Chemical Biology, 7, 31–43
250. Nabors, L. B., Fink, K. L., Mikkelsen, T., Grujicic, D., Tarnawski, R., Nam, D. H., … Zagonel, V. (2015). Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: Results of the open-label, controlled, randomized phase II CORE study. Neuro Oncology, 17, 708–717
251. Naganuma, H., Satoh, E., Asahara, T., Amagasaki, K., Watanabe, A., Satoh, H., … Nukui, H. (2004). Quantification of thrombospondin-1 secretion and expression of alphavbeta3 and alpha3beta1 integrins and syndecan-1 as cell-surface receptors for thrombospondin-1 in malignant glioma cells. Journal of Neurooncology, 70, 309–317
252. Nakada, M., Nakada, S., Demuth, T., Tran, N. L., Hoelzinger, D. B., & Berens, M. E. (2007). Molecular targets of glioma invasion. Cellular and Molecular Life Sciences, 64, 458–478
253. Nakada, M., Niska, J. A., Miyamori, H., McDonough, W. S., Wu, J., Sato, H., & Berens, M. E. (2004). The phosphorylation of EphB2 receptor regulates migration and invasion of human glioma cells. Cancer Research, 64, 3179–3185
254. Nan, Y., Han, L., Zhang, A., Wang, G., Jia, Z., Yang, Y., … Kang, C. (2010). MiRNA-451 plays a role as tumor suppressor in human glioma cells. Brain Research, 1359, 14–21
255. Naumann, U., Harter, P. N., Rubel, J., Ilina, E., Blank, A., Esteban, H. B., & Mittelbronn, M. (2013). Glioma cell migration and invasion as potential target for novel treatment strategies. Translational Neuroscience, 4, 314–329
256. Nedvetzki, S., Gonen, E., Assayag, N., Reich, R., Williams, R. O., Thurmond, R. L., … Turley, E. A. (2004). RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: A different interpretation of redundancy. Proceedings of the National Academy of Sciences of the United States of America, 101, 18081–18086
257. Nevo, I., Woolard, K., Cam, M., Li, A., Webster, J. D., Kotliarov, Y., … Fine, H. A. (2014). Identification of molecular pathways facilitating glioma cell invasion in situ. PLoS One, 9, e111783
258. Newton, H. B. (2004). Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 2: PI3K/Akt/PTEN, mTOR, SHH/PTCH and angiogenesis. Expert Review of Anticancer Therapy, 4, 105–128
259. Noel, A., Maillard, C., Rocks, N., Jost, M., Chabottaux, V., Sounni, N. E., … Foidart, J. M. (2004). Membrane associated proteases and their inhibitors in tumour angiogenesis. Journal of Clinical Pathology, 57, 577–584
260. Nomiyama, H., Hieshima, K., Osada, N., Kato-Unoki, Y., Otsuka-Ono, K., Takegawa, S., … Tanase, S. (2008). Extensive expansion and diversification of the chemokine gene family in zebrafish: Identification of a novel chemokine subfamily CX. BMC Genomics, 9, 222
261. Ödemis, V., Lipfert, J., Kraft, R., Hajek, P., Abraham, G., Hattermann, K., … Engele, J. (2012). The presumed atypical chemokine receptor CXCR7 signals through Gi/oproteins in primary rodent astrocytes and human glioma cells. Glia, 60, 372–381
262. Oellers, P., Schroer, U., Senner, V., Paulus, W., & Thanos, S. (2009). ROCKs are expressed in brain tumors and are required for glioma-cell migration on myelinated axons. Glia, 57, 499–509
263. Ohgaki, H., & Kleihues, P. (2013). The definition of primary and secondary glioblastoma. Clinical Cancer Research, 19, 764–772
264. Ohno-Nakahara, M., Honda, K., Tanimoto, K., Tanaka, N., Doi, T., Suzuki, A., … Ohno, S. (2004). Induction of CD44 and MMP expression by hyaluronidase treatment of articular chondrocytes. Journal of Biochemistry, 135, 567–575
265. Oliva, C., Soldano, A., Mora, N., De Geest, N., Claeys, A., Erfurth, M. L., … Ejsmont, R. K. (2016). Regulation of drosophila brain wiring by neuropil interactions via a slit-robo-RPTP signaling complex. Developmental Cell, 39, 267–278
266. Onishi, M., Ichikawa, T., Kurozumi, K., & Date, I. (2011). Angiogenesis and invasion in glioma. Brain Tumor Pathology, 28, 13–24
267. Overall, C. M., & Lopez, O. C. (2002). Strategies for MMP inhibition in cancer: Innovations for the post-trial era. Nature Reviews Cancer, 2, 657–672
268. Pang, H., Zheng, Y., Zhao, Y., Xiu, X., & Wang, J. (2015). miR-590-3p suppresses cancer cell migration, invasion and epithelial-mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2. Biochemical Biophysical Research Communications, 468, 739–745
269. Pan, I. W., Ferguson, S. D., & Lam, S. (2015). Patient and treatment factors associated with survival among adult glioblastoma patients: A USA population-based study from 2000–2010. Journal of Clinical Neuroscience, 22, 1575–1581
270. Paolillo, M., Serra, M., & Schinelli, S. (2016). Integrins in glioblastoma: Still an attractive target? Pharmacological Research, 113, 55–61
271. Park, J. B., Kwak, H. J., & Lee, S. H. (2008). Role of hyaluronan in glioma invasion. Cell Adhesion & Migration, 2, 202–207
272. Park, M. J., Kim, M. S., Park, I. C., Kang, H. S., Yoo, H., Park, S. H., … Lee, S. H. (2002). PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation. Cancer Research, 62, 6318–6322
273. Parri, M., Buricchi, F., Taddei, M. L., Giannoni, E., Raugei, G., Ramponi, G., & Chiarugi, P. (2005). EphrinA1 repulsive response is regulated by an EphA2 tyrosine phosphatase. Journal of Biological Chemistry, 280, 34008–34018
274. Parri, M., & Chiarugi, P. (2010). Rac and Rho GTPases in cancer cell motility control. Cell Communication Signal, 8, 23
275. Paulus, W., Baur, I., Beutler, A. S., & Reeves, S. A. (1996). Diffuse brain invasion of glioma cells requires beta 1 integrins. Lab Investigation, 75, 819–826
276. Pellegrin, S., & Mellor, H. (2007). Actin stress fibres. Journal of Cell Science, 120, 3491–3499
277. Persson, M., Nedergaard, M. K., Brandt-Larsen, M., Skovgaard, D., Jørgensen, J. T., Michaelsen, S. R., … Kjaer, A. (2016). Urokinase-type plasminogen activator receptor as a potential PET biomarker in glioblastoma. Journal of Nuclear Medicine, 57, 272–278
278. Phillips, J. J., Huillard, E., Robinson, A. E., Ward, A., Lum, D. H., Polley, M. Y., … Werb, Z. (2012). Heparan sulfate sulfatase SULF2 regulates PDGFRalpha signaling and growth in human and mouse malignant glioma. Journal of Clinical Investigation, 122, 911–922
279. Plate, K. H., & Risau, W. (1995). Angiogenesis in malignant gliomas. Glia, 15, 339–347
280. Platten, M., Wick, W., Wild-Bode, C., Aulwurm, S., Dichgans, J., & Weller, M. (2000). Transforming growth factors beta(1) (TGF-beta(1)) and TGF-beta(2) promote glioma cell migration via up-regulation of alpha(V)beta(3) integrin expression. Biochemical and Biophysical Research Communication, 268, 607–611
281. Ponta, H., Sherman, L., & Herrlich, P. A. (2003). CD44: From adhesion molecules to signalling regulators. Nature Reviews Molecular Cell Biology, 4, 33–45
282. Prabha, M., Ramachandra Swamy, N., & Ravi, V. (2013). Specific activity of glycosidases in brain tumors and their expression in primary explants culture. Journal of Biochemical Technology, 5, 654–665
283. Prinz, M., & Mildner, A. (2011). Microglia in the CNS: Immigrants from another world. Glia, 59, 177–187
284. Prydz, K. (2015). Determinants of Glycosaminoglycan (GAG) Structure. Biomolecules, 5, 2003–2022
285. Rangel, M. P., de Sa, V. K., Martins, V., Martins, J. R., Parra, E. R., Mendes, A., … Oliveira, C. Z. (2015). Tissue hyaluronan expression, as reflected in the sputum of lung cancer patients, is an indicator of malignancy. Brazilian Journal of Medical and Biological Research, 48, 557–567
286. Rao, J. S. (2003). Molecular mechanisms of glioma invasiveness: The role of proteases. Nature Reviews Cancer, 3, 489–501
287. Rauch, U. (2007). Brain matrix: Structure, turnover and necessity. Biochemical Society Transactions, 35, 656–660
288. Reifenberger, G., & Collins, V. P. (2004). Pathology and molecular genetics of astrocytic gliomas. Journal of Molecular Medicine (Berl), 82, 656–670
289. Reyes, S. B., Narayanan, A. S., Lee, H. S., Tchaicha, J. H., Aldape, K. D., Lang, F. F., … McCarty, J. H. (2013). alphavbeta8 integrin interacts with RhoGDI1 to regulate Rac1 and Cdc42 activation and drive glioblastoma cell invasion. Molecular Biology of the Cell, 24, 474–482
290. Ricard-Blum, S., & Salza, R. (2014). Matricryptins and matrikines: Biologically active fragments of the extracellular matrix. Experimental Dermatology, 23, 457–463
291. Rieger, J., Wick, W., & Weller, M. (2003). Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins. Glia, 42, 379–389
292. Rivera, S., Khrestchatisky, M., Kaczmarek, L., Rosenberg, G. A., & Jaworski, D. M. (2010). Metzincin proteases and their inhibitors: Foes or friends in nervous system physiology? Journal of Neuroscience, 30, 15337–15357
293. Rooprai, H. K., Vanmeter, T., Panou, C., Schnull, S., Trillo-Pazos, G., Davies, D., & Pilkington, G. J. (1999). The role of integrin receptors in aspects of glioma invasion in vitro. International Journal of Developmental Neuroscience, 17, 613–623
294. Rosen, S. D., & Lemjabbar-Alaoui, H. (2010). Sulf-2: An extracellular modulator of cell signaling and a cancer target candidate. Expert Opinion on Therapeutic Targets, 14, 935–949
295. Rotoli, D., Pérez-Rodríguez, N. D., Morales, M., Maeso, M. D., Ávila, J., Mobasheri, A., & Martín-Vasallo, P. (2017). IQGAP1 in podosomes/invadosomes is involved in the progression of glioblastoma multiforme depending on the tumor status. International Journal of Molecular Sciences, 18, E150
296. Ruoslahti, E., & Yamaguchi, Y. (1991). Proteoglycans as modulators of growth factor activities. Cell, 64, 867–869
297. Sakamoto, S., Ishizaki, T., Okawa, K., Watanabe, S., Arakawa, T., Watanabe, N., & Narumiya, S. (2012). Liprin-alpha controls stress fiber formation by binding to mDia and regulating its membrane localization. Journal of Cell Science, 125, 108–120
298. Sakariassen, P. O., Prestegarden, L., Wang, J., Skaftnesmo, K. O., Mahesparan, R., Molthoff, C., … Tysnes, B. B. (2006). Angiogenesis-independent tumor growth mediated by stem-like cancer cells. Proceedings of the National Academy of Sciences of the United States of America, 103, 16466–16471
299. Salazar, N., Castellan, M., Shirodkar, S. S., & Lokeshwar, B. L. (2013). Chemokines and chemokine receptors as promoters of prostate cancer growth and progression. Critical Reviews in Eukaryotic Gene Expression, 23, 77–91
300. Salhia, B., Tran, N. L., Chan, A., Wolf, A., Nakada, M., Rutka, F., … Symons, M. (2008). The guanine nucleotide exchange factors trio, Ect2, and Vav3 mediate the invasive behavior of glioblastoma. American Journal of Pathology, 173, 1828–1838
301. Savagner, P. (2010). The epithelial-mesenchymal transition (EMT) phenomenon. Annals of Oncology, 21Suppl7, vii89–vii92
302. Schaller, M. D. (2010). Cellular functions of FAK kinases: Insight into molecular mechanisms and novel functions. Journal of Cell Science, 123, 1007–1013
303. Schmid, P., Cox, D., Bilbe, G., Maier, R., & McMaster, G. K. (1991). Differential expression of TGF beta 1, beta 2 and beta 3 genes during mouse embryogenesis. Development, 111, 117–130
304. Schultz, G. S., & Wysocki, A. (2009). Interactions between extracellular matrix and growth factors in wound healing. Wound Repair and Regeneration, 17, 153–162
305. Schwertfeger, K. L., Cowman, M. K., Telmer, P. G., Turley, E. A., & McCarthy, J. B. (2015). Hyaluronan, Inflammation, and Breast Cancer Progression. Frontiers in Immunology, 6, 236
306. Sciumè, G., Soriani, A., Piccoli, M., Frati, L., Santoni, A., & Bernardini, G. (2010). CX3CR1/CX3CL1 axis negatively controls glioma cell invasion and is modulated by transforming growth factor-beta1. Neuro Oncology, 12, 701–710
307. Seidenbecher, C. I., Richter, K., Rauch, U., Fassler, R., Garner, C. C., & Gundelfinger, E. D. (1995). Brevican, a chondroitin sulfate proteoglycan of rat brain, occurs as secreted and cell surface glycosylphosphatidylinositol-anchored isoforms. Journal of Biological Chemistry, 270, 27206–27212
308. Seidenbecher, C. I., Smalla, K. H., Fischer, N., Gundelfinger, E. D., & Kreutz, M. R. (2002). Brevican isoforms associate with neural membranes. Journal of Neurochemistry, 83, 738–746
309. Serafini, T., Colamarino, S. A., Leonardo, E. D., Wang, H., Beddington, R., Skarnes, W. C., & Tessier-Lavigne, M. (1996). Netrin-1 is required for commissural axon guidance in the developing vertebrate nervous system. Cell, 87, 1001–1014
310. Serna, E., Lopez-Gines, C., Monleon, D., Munoz-Hidalgo, L., Callaghan, R. C., Gil-Benso, R., … Cerda-Nicolas, M. (2014). Correlation between EGFR amplification and the expression of microRNA-200c in primary glioblastoma multiforme. PLoS One, 9, e102927
311. Seufert, S., Coras, R., Trankle, C., Zlotos, D. P., Blumcke, I., Tatenhorst, L., … Hahnen, E. (2008). PPAR gamma activators: Off-target against glioma cell migration and brain invasion. PPAR Research, 2008, 513943
312. Sherman, L. S., Struve, J. N., Rangwala, R., Wallingford, N. M., Tuohy, T. M. F., & Kuntz, I. V. C. (2002). Hyaluronate-based extracellular matrix: Keeping glia in their place. Glia, 38, 93–102
313. Shimizu, A., Nakayama, H., Wang, P., Konig, C., Akino, T., Sandlund, J., … Bielenberg, D. R. (2013). Netrin-1 promotes glioblastoma cell invasiveness and angiogenesis by multiple pathways including activation of RhoA, cathepsin B, and cAMP-response element-binding protein. Journal of Biological Chemistry, 288, 2210–2222
314. Shuang, Z. Y., Wu, W. C., Xu, J., Lin, G., Liu, Y. C., Lao, X. M., … Li, S. (2014). Transforming growth factor-beta1-induced epithelial-mesenchymal transition generates ALDH-positive cells with stem cell properties in cholangiocarcinoma. Cancer Letters, 354, 320–328
315. Siebzehnrubl, F. A., Silver, D. J., Tugertimur, B., Deleyrolle, L. P., Siebzehnrubl, D., Sarkisian, M. R., … Steindler, D. A. (2013). The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance. EMBO Molecular Medicine, 5, 1196–1212
316. Siiskonen, H., Poukka, M., Tyynela-Korhonen, K., Sironen, R., & Pasonen-Seppanen, S. (2013). Inverse expression of hyaluronidase 2 and hyaluronan synthases 1–3 is associated with reduced hyaluronan content in malignant cutaneous melanoma. BMC Cancer, 13, 181
317. Silginer, M., Weller, M., Ziegler, U., & Roth, P. (2014). Integrin inhibition promotes atypical anoikis in glioma cells. Cell Death & Disease, 5, e1012
318. Simpson, M. A., & Lokeshwar, V. B. (2008). Hyaluronan and hyaluronidase in genitourinary tumors. Frontiers in Bioscience, 13, 5664–5680
319. Singh, A. K., Arya, R. K., Trivedi, A. K., Sanyal, S., Baral, R., Dormond, O., … Datta, D. (2013). Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12. Cytokine Growth Factor Review, 24, 41–49
320. Sivasankaran, B., Degen, M., Ghaffari, A., Hegi, M. E., Hamou, M. F., Ionescu, M. C., … Mergenthaler, S. (2009). Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomas. Cancer Research, 69, 458–465
321. Skandalis, S. S., Kletsas, D., Kyriakopoulou, D., Stavropoulos, M., & Theocharis, D. A. (2006). The greatly increased amounts of accumulated versican and decorin with specific post-translational modifications may be closely associated with the malignant phenotype of pancreatic cancer. Biochimica Biophysica Acta, 1760, 1217–1225
322. Son, H., & Moon, A. (2010). Epithelial-mesenchymal Transition and Cell Invasion. Toxicology Research, 26, 245–252
323. Stanton, H., Melrose, J., Little, C. B., & Fosang, A. J. (2011). Proteoglycan degradation by the ADAMTS family of proteinases. Biochimica Biophysica Acta, 1812, 1616–1629
324. Steeg, P. S., Camphausen, K. A., & Smith, Q. R. (2011). Brain metastases as preventive and therapeutic targets. Nature Reviews Cancer, 11, 352–363
325. Steffen, A., Koestler, S. A., & Rottner, K. (2014). Requirements for and consequences of Rac-dependent protrusion. European Journal of Cell Biology, 93, 184–193
326. Steinle, J. J., Meininger, C. J., Chowdhury, U., Wu, G., & Granger, H. J. (2003). Role of ephrin B2 in human retinal endothelial cell proliferation and migration. Cell Signal, 15, 1011–1017
327. Straume, O., Chappuis, P. O., Salvesen, H. B., Halvorsen, O. J., Haukaas, S. A., Goffin, J. R., … Akslen, L. A. (2002). Prognostic importance of glomeruloid microvascular proliferation indicates an aggressive angiogenic phenotype in human cancers. Cancer Research, 62, 6808–6811
328. Stuhlmeier, K. M. (2006). Aspects of the biology of hyaluronan, a largely neglected but extremely versatile molecule. Wiener Medizinische Wochensschrift, 156, 563–568
329. Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J., … Bogdahn, U. (2005). Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New England Journal of Medicine, 352, 987–996
330. Stylli, S. S., Kaye, A. H., & Lock, P. (2008). Invadopodia: At the cutting edge of tumour invasion. Journal of Clinical Neuroscience, 15, 725–737
331. Su, G., Meyer, K., Nandini, C. D., Qiao, D., Salamat, S., & Friedl, A. (2006). Glypican-1 is frequently overexpressed in human gliomas and enhances FGF-2 signaling in glioma cells. American Journal of Pathology, 168, 2014–2026
332. Sun, B. O., Fang, Y., Li, Z., Chen, Z., & Xiang, J. (2015). Role of cellular cytoskeleton in epithelial-mesenchymal transition process during cancer progression. Biomedical Reports, 3, 603–610
333. Suzuki, Y., Fujioka, K., Ikeda, K., Murayama, Y., & Manome, Y. (2017). Temozolomide does not influence the transcription or activity of matrix metalloproteinases 9 and 2 in glioma cell lines. Journal of Clinical Neuroscience, 41, 144–149
334. Tabouret, E., Boudouresque, F., Farina, P., Barrie, M., Bequet, C., Sanson, M., & Chinot, O. (2015). MMP2 and MMP9 as candidate biomarkers to monitor bevacizumab therapy in high-grade glioma. Neuro Oncology, 17, 1174–1176
335. Takada, Y., Ye, X., & Simon, S. (2007). The integrins. Genome Biology, 8, 215
336. Tamura, R., Tanaka, T., Miyake, K., Yoshida, K., & Sasaki, H. (2017). Bevacizumab for malignant gliomas: Current indications, mechanisms of action and resistance, and markers of response. Brain Tumor Pathology, 34, 62–77
337. Tan, J. X., Wang, X. Y., Su, X. L., Li, H. Y., Shi, Y., Wang, L., & Ren, G. S. (2011). Upregulation of HYAL1 expression in breast cancer promoted tumor cell proliferation, migration, invasion and angiogenesis. PLoS One, 6, e22836
338. Tan, K. W., Evrard, M., Tham, M., Hong, M., Huang, C., Kato, M., … Abastado, J. P. (2015). Tumor stroma and chemokines control T-cell migration into melanoma following Temozolomide treatment. Oncoimmunology, 4, e978709
339. Tapon, N., & Hall, A. (1997). Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Current Opinion in Cell Biology, 9, 86–92
340. Tarus, D., Hamard, L., Caraguel, F., Wion, D., Szarpak-Jankowska, A., van der Sanden, B., & Auzély-Velty, R. (2016). Design of hyaluronic acid hydrogels to promote neurite outgrowth in three dimensions. ACS Applied Materials & Interfaces, 8, 25051–25059
341. Tessier-Lavigne, M., & Goodman, C. S. (1996). The molecular biology of axon guidance. Science, 274, 1123–1133
342. Toole, B. P. (2004). Hyaluronan: From extracellular glue to pericellular cue. Nature Reviews Cancer, 4, 528–539
343. Treasurywala, S., & Berens, M. E. (1998). Migration arrest in glioma cells is dependent on the alphav integrin subunit. Glia, 24, 236–243
344. Trebaul, A., Chan, E. K., & Midwood, K. S. (2007). Regulation of fibroblast migration by tenascin-C. Biochemical Society Transactions, 35, 695–697
345. Tsukita, S., Oishi, K., Sato, N., Sagara, J., Kawai, A., & Tsukita, S. (1994). ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. Journal of Cell Biology, 126, 391–401
346. Twarock, S., Tammi, M. I., Savani, R. C., & Fischer, J. W. (2010). Hyaluronan stabilizes focal adhesions, filopodia, and the proliferative phenotype in esophageal squamous carcinoma cells. Journal of Biological Chemistry, 285, 23276–23284
347. Uchimura, K., Morimoto-Tomita, M., Bistrup, A., Li, J., Lyon, M., Gallagher, J., … Rosen, S. D. (2006). HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: Effects on VEGF, FGF-1, and SDF-1. BMC Biochemistry, 7, 2
348. Ueno, H., Tomiyama, A., Yamaguchi, H., Uekita, T., Shirakihara, T., Nakashima, K., … Mori, K. (2015). Augmentation of invadopodia formation in temozolomide-resistant or adopted glioma is regulated by c-Jun terminal kinase-paxillin axis. Biochemical and Biophysical Research Communications, 468, 240–247
349. Ulrich, T. A., de Juan Pardo, E. M., & Kumar, S. (2009). The mechanical rigidity of the extracellular matrix regulates the structure, motility, and proliferation of glioma cells. Cancer Research, 69, 4167–4174
350. Valin, A., & Pablos, J. L. (2015). The Role of the Transcriptional Regulation of Stromal Cells in Chronic Inflammation. Biomolecules, 5, 2723–2757
351. Varga, I., Hutóczki, G., Szemcsák, C. D., Zahuczky, G., Tóth, J., Adamecz, Z., … Klekner, A. (2012). Brevican, neurocan, tenascin-C and versican are mainly responsible for the invasiveness of low-grade astrocytoma. Pathology & Oncology Research, 18, 413–420
352. Vargová, L., Homola, A., Zámecník, J., Tichý, M., Benes, V., & Syková, E. (2003). Diffusion parameters of the extracellular space in human gliomas. Glia, 42, 77–88
353. Vega, E. A., Graner, M. W., & Sampson, J. H. (2008). Combating immunosuppression in glioma. Future Oncology, 4, 433–442
354. Vehlow, A., Klapproth, E., Storch, K., Dickreuter, E., Seifert, M., Dietrich, A., … Cordes, N. (2017). Adhesion- and stress-related adaptation of glioma radiochemoresistance is circumvented by beta1 integrin/JNK co-targeting. Oncotarget, 8, 49224–49237
355. Viapiano, M. S., Bi, W. L., Piepmeier, J., Hockfield, S., & Matthews, R. T. (2005). Novel tumor-specific isoforms of BEHAB/brevican identified in human malignant gliomas. Cancer Research, 65, 6726–6733
356. Viapiano, M. S., Matthews, R. T., & Hockfield, S. (2003). A novel membrane-associated glycovariant of BEHAB/brevican is up-regulated during rat brain development and in a rat model of invasive glioma. Journal of Biological Chemistry, 278, 33239–33247
357. Villegas-Ruíz, V., Salcedo, M., Zentella-Dehesa, A., de Oca, E. V., Román-Basaure, E., Mantilla-Morales, A., … Juárez-Méndez, S. (2014). A case of cervical cancer expressed three mRNA variant of Hyaluronan-mediated motility receptor. International Journal of Clinical and Experimental Pathology, 7, 2256–2264
358. Vindrieux, D., Escobar, P., & Lazennec, G. (2009). Emerging roles of chemokines in prostate cancer. Endocrine-Related Cancer, 16, 663–673
359. Vinnakota, K., Hu, F., Ku, M. C., Georgieva, P. B., Szulzewsky, F., Pohlmann, A., … Lehnardt, S. (2013). Toll-like receptor 2 mediates microglia/brain macrophage MT1-MMP expression and glioma expansion. Neuro Oncology, 15, 1457–1468
360. Vlodavsky, I., Elkin, M., & Ilan, N. (2011). Impact of heparanase and the tumor microenvironment on cancer metastasis and angiogenesis: Basic aspects and clinical applications. Rambam Maimonides Medical Journal, 2, e0019
361. Vornicova, O., Boyango, I., Feld, S., Naroditsky, I., Kazarin, O., Zohar, Y., … Vlodavsky, I. (2016). The prognostic significance of heparanase expression in metastatic melanoma. Oncotarget, 7, 74678–74685
362. Wade, A., Robinson, A. E., Engler, J. R., Petritsch, C., James, C. D., & Phillips, J. J. (2013). Proteoglycans and their roles in brain cancer. Febs Journal, 280, 2399–2417
363. Wang, C., Thor, A. D., Moore, D. H., 2nd, Zhao, Y., Kerschmann, R., Stern, R., … Turley, E. A. (1998). The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression. Clinical Cancer Research, 4, 567–576
364. Wang, H., Tang, C., Na, M., Ma, W., Jiang, Z., Gu, Y., … Lin, Z. (2017). miR-422a Inhibits Glioma Proliferation and Invasion by Targeting IGF1 and IGF1R. Oncology Research, 25, 187–194
365. Wang, S. D., Rath, P., Lal, B., Richard, J. P., Li, Y., Goodwin, C. R., … Xia, S. (2012). EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase. Oncogene, 31, 5132–5143
366. Whatcott, C. J., Han, H., Posner, R. G., Hostetter, G., & Von Hoff, D. D. (2011). Targeting the tumor microenvironment in cancer: Why hyaluronidase deserves a second look. Cancer Discovery, 1, 291–296
367. Wick, W., Naumann, U., & Weller, M. (2006). Transforming growth factor-beta: A molecular target for the future therapy of glioblastoma. Current Pharmaceutical Design, 12, 341–349
368. Wick, W., Platten, M., & Weller, M. (2001). Glioma cell invasion: Regulation of metalloproteinase activity by TGF-beta. Journal of Neurooncology, 53, 177–185
369. Wight, T. N. (2017). Provisional matrix: A role for versican and hyaluronan. Matrix Biology, 60–61, 38–56
370. Williams, S. A., & Schwarzbauer, J. E. (2009). A shared mechanism of adhesion modulation for tenascin-C and fibulin-1. Molecular Biology of Cell, 20, 1141–1149
371. Winkler, F., Kienast, Y., Fuhrmann, M., Von Baumgarten, L., Burgold, S., Mitteregger, G., … Herms, J. (2009). Imaging glioma cell invasion in vivo reveals mechanisms of dissemination and peritumoral angiogenesis. Glia, 57, 1306–1315
372. Winograd-Katz, S. E., Fassler, R., Geiger, B., & Legate, K. R. (2014). The integrin adhesome: From genes and proteins to human disease. Nature Reviews Molecular Cell Biology, 15, 273–288
373. Wiranowska, M., Ladd, S., Smith, S. R., & Gottschall, P. E. (2006). CD44 adhesion molecule and neuro-glial proteoglycan NG2 as invasive markers of glioma. Brain Cell Biology, 35, 159–172
374. Wiranowska, M., & Rojiani, M. V. (2011). Extracellular Matrix Microenvironment in Glioma Progression, Glioma – Exploring Its Biology and Practical Relevance. In: Dr Anirban Ghosh (Ed). InTech. https://doi.org/10.5772/24666 Retrieved from: https://www.intechopen.com/books/glioma-exploring-its-biology-and-practical-relevance/extracellular-matrix-microenvironment-in-glioma-progression
375. Wirsching, H. G., Galanis, E., & Weller, M. (2016). Glioblastoma. Handbook of Clinical Neurology, 134, 381–397
376. Wu, D. G., Wang, Y. Y., Fan, L. G., Luo, H., Han, B., Sun, L. H., … Wang, X. R. (2011). MicroRNA-7 regulates glioblastoma cell invasion via targeting focal adhesion kinase expression. Chinese Medical Journal (Engl), 124, 2616–2621
377. Xu, Y., Yuan, J., Zhang, Z., Lin, L., & Xu, S. (2012). Syndecan-1 expression in human glioma is correlated with advanced tumor progression and poor prognosis. Molecular Biology Reports, 39, 8979–8985
378. Xue, H., Guo, X., Han, X., Yan, S., Zhang, J., Xu, S., … Gao, X. (2016). MicroRNA-584-3p, a novel tumor suppressor and prognostic marker, reduces the migration and invasion of human glioma cells by targeting hypoxia-induced ROCK1. Oncotarget, 7, 4785–4805
379. Yamada, N., Kato, M., Yamashita, H., Nistér, M., Miyazono, K., Heldin, C. H., & Funa, K. (1995). Enhanced expression of transforming growth factor-beta and its type-I and type-II receptors in human glioblastoma. Internatuional Journal of Cancer, 62, 386–392
380. Yan, Y. R., Xie, Q., Li, F., Zhang, Y., Ma, J. W., Xie, S. M., … Zhong, X. Y. (2014). Epithelial-to-mesenchymal transition is involved in BCNU resistance in human glioma cells. Neuropathology, 34, 128–134
381. Yoshida, Y. (2012). Semaphorin signaling in vertebrate neural circuit assembly. Frontiers in Molecular Neuroscience, 5, 71
382. Yue, B. (2014). Biology of the extracellular matrix: An overview. Journal of Glaucoma, 23, S20–S23
383. Yung, A. R., Nishitani, A. M., & Goodrich, L. V. (2015). Phenotypic analysis of mice completely lacking netrin 1. Development, 142, 3686–3691
384. Yurchenco, P. D. (2011). Basement membranes: Cell scaffoldings and signaling platforms. Cold Spring Harbor Perspectives Biology, 3.
385. Zagzag, D., Lukyanov, Y., Lan, L., Ali, M. A., Esencay, M., Mendez, O., … Newcomb, E. W. (2006). Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: Implications for angiogenesis and glioma cell invasion. Lab Investigation, 86, 1221–1232
386. Zaidel-Bar, R., Itzkovitz, S., Ma'ayan, A., Iyengar, R., & Geiger, B. (2007). Functional atlas of the integrin adhesome. Nature Cell Biology, 9, 858–867
387. Zetser, A., Bashenko, Y., Edovitsky, E., Levy-Adam, F., Vlodavsky, I., & Ilan, N. (2006). Heparanase induces vascular endothelial growth factor expression: Correlation with p38 phosphorylation levels and Src activation. Cancer Research, 66, 1455–1463
388. Zetser, A., Bashenko, Y., Miao, H. Q., Vlodavsky, I., & Ilan, N. (2003). Heparanase affects adhesive and tumorigenic potential of human glioma cells. Cancer Research, 63, 7733–7741
389. Zhang, H., Kelly, G., Zerillo, C., Jaworski, D. M., & Hockfield, S. (1998). Expression of a cleaved brain-specific extracellular matrix protein mediates glioma cell invasion In vivo. Journal of Neuroscience, 18, 2370–2376
390. Zhang, J., Tian, X. J., & Xing, J. (2016). Signal transduction pathways of EMT induced by TGF-beta, SHH, and WNT and their crosstalks. Journal of Clinical Medicine, 5(4), 41
391. Zhao, K., Wang, L., Li, T., Zhu, M., Zhang, C., Chen, L., … Yang, X. (2017). The role of miR-451 in the switching between proliferation and migration in malignant glioma cells: AMPK signaling, mTOR modulation and Rac1 activation required. International Journal of Oncology, 50, 1989–1999
392. Zhou, P., Erfani, S., Liu, Z., Jia, C., Chen, Y., Xu, B. … Others, (2015). CD151-alpha3beta1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion. Oncotarget, 6, 29675–29693
393. Zhu, Y., Zhao, H., Rao, M., & Xu, S. (2017). MicroRNA-365 inhibits proliferation, migration and invasion of glioma by targeting PIK3R3. Oncology Reports, 37, 2185–2192
394. Zimmermann, D. R., & Dours-Zimmermann, M. T. (2008). Extracellular matrix of the central nervous system: From neglect to challenge. Histochemistry and Cell Biology, 130, 635–653
395. Zlotnik, A., & Yoshie, O. (2000). Chemokines: A new classification system and their role in Immunity. Immunity, 12, 7